Relative homogeneity of oral bacterial flora in Crohn’s disease compared to ulcerative colitis and its connections with antioxidant defense — preliminary report by Szczeklik, Katarzyna et al.
FOLIA MEDICA CRACOVIENSIA
Vol. LIX, 1, 2019: 15–35
PL ISSN 0015-5616
DOI: 10.24425/fmc.2019.128023
Relative homogeneity of oral bacterial fl ora
in Crohn’s disease compared to ulcerative colitis
and its connections with antioxidant defense
— preliminary report
Katarzyna Szczeklik1, Danuta Owczarek2, Dorota Cibor2,
Marta Cześnikiewicz-Guzik3, Paweł Krzyściak4, Agnieszka Krawczyk5,
Tomasz Mach2, Elżbieta Karczewska6, Wirginia Krzyściak7
1Department of Integrated Dentistry, Jagiellonian University Medical College, Kraków, Poland
2Department of Gastroenterology, Hepatology and Infectious Diseases, Jagiellonian University Medical College 
Kraków, Poland
3Department of Dental Prophylaxis and Experimental Dentistry, Jagiellonian University Medical College
Kraków, Poland
4Department of Mycology, Chair of Microbiology, Jagiellonian University Medical College, Kraków, Poland
5 Student Association of Department of Medical Diagnostics, Faculty of Pharmacy
Jagiellonian University Medical College, Kraków, Poland
6Department of Pharmaceutical Microbiology, Jagiellonian University Medical College, Kraków, Poland
7Department of Medical Diagnostics, Faculty of Pharmacy, Jagiellonian University Medical College
Kraków, Poland
Corresponding author: Katarzyna Szczeklik, DDs, PhD
Department of Integrated Dentistry, Jagiellonian University Medical College, Kraków, Poland
ul. Montelupich 4, 31-155 Kraków, Poland
Phone: +48 12 424 55 55; E-mail: k.szczeklik@uj.edu.pl
Abstract: I n t r o d u c t i o n: Interactions between oral microbiota and systemic diseases have been 
suggested. We aimed to examine the composition of oral microbiota with reference to antioxidative defense 
and its correlation with clinical state in Crohn’s disease (CD) in comparison to ulcerative colitis (UC).
M a t e r i a l s  a n d  M e t h o d s: Smears were taken from the buccal and tongue mucosa of patients with 
CD, UC and controls, and cultured with classical microbiology methods. Bacterial colonies were identifi ed 
using matrix-assisted laser desorption/ionization (MALDI) with a time-of-fl ight analyzer (TOF). Blood 
morphology and C-reactive protein (CRP) were analyzed in the hospital laboratory. Antioxidative defense 
potential (FRAP) was determined using spectrophotometry in saliva and serum.
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R e s u l t s: Oral microbiota in CD patients were characterized by lower diversity in terms of the isolated 
bacteria species compared to UC and this correlated with reduced FRAP in the oral cavity and intensifi ed 
systemic infl ammation. Oral microbiota composition in CD did not depend on the applied treatment. In 
CD patients, a negative correlation was observed between the FRAP value in saliva and serum and the 
CRP value in serum. Individual diff erences in the composition of oral microbiota suggest that diff erent 
bacteria species may be involved in the induction of oxidative stress associated with a weakening of 
antioxidative defense in the oral cavity, manifested by ongoing systemic infl ammation.
C o n c l u s i o n s: Analysis of both the state of the microbiota and antioxidative defense of the oral 
cavity, as well as their referencing to systemic infl ammation may potentially prove helpful in routine 
diagnostic applications and in aiding a better understanding of CD and UC pathogenesis associated with 
oral microbiota.
Key words: Crohn’s disease, ulcerative colitis, oral microbiota, antioxidant.
Introduction
Current developments in technology leading to research on the human microbiome 
indicate that a healthy oral cavity is colonized by bacteria, which thus far have been 
seen as etiological factors of individual local diseases, such as periodontitis, halitosis 
or dental caries [1, 2]. Presently, the idea of only selected, single bacteria species being 
etiological factors of diseases is being abandoned for the theory of ecology, explaining 
the role of associated microbiota in the disturbance of the microbiological equilibrium 
and the formation of individual pathological states. Th e role of interactions between 
the external environment and microorganisms and the immunologically susceptible 
host is emphasized, thanks to which interspecifi c shift s and dysbiosis occur, leading 
to the development of numerous diseases, such as non-specifi c enteritis, including 
Crohn’s disease (CD) and ulcerative colitis (UC) [3, 4].
An altered microbiota of the oral cavity has been observed in CD and other 
systemic diseases, such as diabetes, bacteremia, endocarditis, cancers or autoimmune 
diseases [5–8]. Thus, it is important to find a relationship between oral bacteria 
diversity and other oral biomarkers and their impact on the pathophysiology of 
various diseases. Information obtained in this manner through the assessment of 
relationships with the remaining systemic biomarkers may be used to develop new 
algorithms. Th e use of biomarkers obtained using low invasiveness methods based on 
widely accessible material, that is saliva or oral cavity smears, may be applicable in 
early diagnostics or monitoring of the state of these diseases.
Based on our own study [9, 10], the production of reactive oxygen species (ROS) 
in patients with CD strictly depends on the infl ammatory process in the organism 
and it may contribute to disturbance of the oxidative—antioxidative balance.
Disturbances in ROS levels within the oral cavity may be the result of changes 
occurring under impact from oral bacterial fl ora. Th is is caused when microorganisms 
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capable of producing a disease are absorbed by immunity cells of the host such as 
neutrophils, macrophages and fi broblasts, thus forming ROS and reactive nitrogen 
species (RNS).
Excessive ROS and RNS, without effi  cient repair systems, results in structural and 
functional changes to proteins, lipids and nucleic acids. Byproducts of these reactions 
penetrate into the blood, urea or saliva, and thus some may be used as disease 
predictors, reflecting intensification of the ongoing inflammation or dynamically 
developing oxidative stress (OxS) [11, 12]. Unlike other diseases no detailed studies 
into CD have published results of OxS among bacteria of the oral cavity microbiota in 
adults [13–15].
In response to elevated bacterial invasion, the immune system of the host 
commences elimination of microbes through increased OxS and elevated salivary 
antioxidant production. The role of antioxidants in health and disease and the 
mechanisms associated with inclusion/exclusion of antioxidants is not fully 
understood. Interactions between microorganisms and the patient and the resulting 
action of the antioxidative systems of the host depend on numerous factors, 
including the predominant bacteria species, and the antioxidative systems may act 
jointly or independently of the antioxidative systems of the host. At the same time, 
the role of extrinsic factors, such as diet, and nutritional and hygienic behavior, is 
also important.
Immune system cells, such as neutrophils, macrophages or fi broblasts found in the 
oral cavity, are capable of active production ROS or RNS to combat microorganisms 
and microorganisms may infl uence the effi  ciency of the antioxidative systems of the 
host. As an example, certain bacteria of the oral cavity, such as Enterococci, are capable 
of endogenous ROS production, which contributes to the growth of OxS markers in 
the saliva and makes the interpretation of salivary antioxidant activity more diffi  cult 
than would be the case with sole measurement of salivary antioxidant indicators. 
Th ese data indicate the importance of the assessment of the relationship between the 
microbiome and the immune system of the host. Worthy of determination is also 
the relationship between the variability of the indicators of OxS over time and the 
oral microbiota composition in patients with CD in comparison to UC. Biological 
rhythms associated with food consumed and their variation over time may impact 
upon the induction of OxS and nitrosative stress as a symptom of unstable signaling 
between the microbiome and the host and the result of oral microbiota composition 
variability. Th is is proven by the fact that the levels of oxidative stress indicators 
increase aft er a meal, which stimulates growth of certain pathogenic bacteria and 
increased metabolism (e.g., S. mutans), disturbing the proportions in the oral 
microbiome. Th us, the hypothesis we sought to verify concerns variability over time 
of OxS levels in saliva and its association with the composition of the oral microbiota, 
which will stimulate ROS/RNS production.
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Th e presented study demonstrates the composition of the oral microbiota with 
reference to antioxidative defense elements and their correlation with clinical state, as 
well as systemic infl ammation in CD in comparison to UC.
Materials and Methods
Study population
Consecutive adult patients with CD and UC were enrolled. Th e study population 
included 18 subjects with CD (age 26–64 years) and 13 with UC (age 26–67). CD 
and UC were diagnosed based on classic, endoscopic, histological and radiological 
criteria [16, 17]. Th e patients were recruited from the Division of Gastroenterology 
and Hepatology at the University Hospital in Kraków, Poland. Th e controls were 
represented by 5 healthy volunteers recruited from the hospital staff . Th e exclusion 
criteria were the following: any known systemic infection or disease, pregnancy 
or lactation, alcoholism, tobacco smoking, use of antibiotics, antioxidants 
(e.g., vitamins C, E) or anti-infl ammatory drugs within the last 6 months, periodontal 
disease, presence of an oral mucosal infl ammatory condition (e.g., aphthous, lichen 
planus, leukoplakia), removable orthodontic appliances, and symptoms of acute 
infectious illness (e.g., fever, sore throat).
Th e study was performed in accordance with the ethical principles of the Helsinki 
Declaration of 2008. Informed consent to the study procedure was obtained from all 
participants. Th e protocol was approved by the Bioethics Committee of Jagiellonian 
University in Kraków, Poland (KBET/200/B/2014). All individuals provided written 
informed consent to participate in the study.
Clinical assessment
Clinical assessment included the presence of comorbidities, cigarette-smoking 
habits, and medications. In patients with CD and UC, the following parameters were 
evaluated: disease duration, disease location, disease activity, complications, and past 
surgical procedures. Complications were defi ned as abscesses, fi stulae, and stenoses 
resulting in post-obstructive symptoms. To determine the location of lesions in CD 
and UC patients, the Montreal classifi cation was employed [18]. To assess CD and 
UC activity, the CD activity index and UC activity index were used [19, 20].
Saliva sampling
Saliva samples were collected from all participants using a Salivette® Cotton Swab 
system (Sarstedt AG & Co., Numbrecht, Germany). Th e fasted subject rinsed their 
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mouth with tap water for 30 s and expectorated it before saliva collection, placed 
a  cotton swab in their mouth and chewed it for 3 min. to stimulate salivation. 
Salivettes with swabs saturated with saliva were centrifuged at 1000 rpm for 2 min. 
at 4°C. Clear saliva samples (about 1 ml) were immediately aliquoted to sterile 0.2 ml 
micro test tubes, Eppendorf type, and frozen at −80°C until assayed.
Laboratory tests
Fasting blood samples were collected from the antecubital vein in the morning. On 
the same day, the following laboratory parameters were determined: complete blood 
count, CRP, and iron and albumin concentrations in serum. Complete blood count 
was performed with a Sysmex XE-2100 hematology automated analyzer (Sysmex, 
Kobe, Germany). CRP, iron and albumin were assayed using a Modular P clinical 
chemistry analyzer (Roche Diagnostics, Mannheim, Germany). Additional blood 
samples were centrifuged at 3000 × g for 10 min at 4°C, and plasma samples were 
stored at −80°C for determination of FRAP and protein.
Total antioxidant potential (FRAP assay)
FRAP levels in plasma and saliva were measured according to the method of Benzie 
and Strain [21, 10]. Th e plasma and saliva samples were mixed with 3 ml reagent 
mixture containing acetate buff er (pH 3.6), 5 mM tripyridyltriazine in 40  mM HCl, 
and 20 mM ferric chloride. FRAP values were calculated by preparing an aqueous 
solution of known FeII (FeSO4 ∙ 7H2O) concentration in the range of 0–1.0 mM and 
a blank containing FRAP reagent mixture. Absorbance was assessed at a  wavelength 
of 593 nm (FLUOstar Omega spectrophotometer; BMG Labtech). FRAP values were 
expressed as mM/mg of protein.
Concentrations of total protein in plasma and saliva were measured using 
the bicinchonic acid (BCA) method according to the manufacturer’s instructions 
(Sigma-Aldrich, USA), as described previously [10, 15]. Th e BCA method entails 
reducing Cu2+ to Cu+, and Cu+ ions react in an alkaline medium with BCA, which 
gives it a violet color. Absorbance was read at a wavelength of 562 nm at 37°C 
(FLUOstar Omega spectrophotometer; BMG Labtech), and a calibration curve was 
plotted and a simple linear regression equation derived. Protein concentrations were 
expressed in mg/mL [10].
Microbiological methods
Smears from the mucosa of the cheek and the dorsal portion of the tongue were 
collected with a sterile cotton swab. Th e samples were transported within 4 hours to 
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the laboratory in 1 ml sterile physiological saline, pH 7.0 (PBS) at room temperature. 
Th e samples were disrupted by gentle vortexing and sonication for 30 s. Subsequently, 
serial dilutions of the starting solution were prepared in sterile physiological saline. 
Samples with the above dilutions were inoculated on plates with 10% blood agar and on 
selective media used to detect certain microorganism groups. Th e following selective 
media were subsequently used: CHROMagarTM chromogenic agar supporting growth 
of Candida and yeasts supporting gr agar for Enterococci (BD Enterococcosel Agar), 
and BD MacConkey II Agar selective medium intended for the Coli group bacteria 
(CCA); and chromogenic agar for isolation and diff erentiation of Enterobacteriaceae. 
Th e inoculated media were incubated in microaerophilic conditions in the presence 
of 5% CO2 at a temperature of 37°C over a period of 24–48 hours. Based on their 
morphology, colonies of yeasts, Enterococci, Enterobacteriaceae and Staphylococci 
grown on selective media were counted. Distinct microorganism species were isolated 
and cultured on media dedicated to growth and diff erentiation of microorganisms, in 
order to obtain clear isolates for further identifi cation. Th e preliminary identifi cation 
was performed based on microscopic examination of preparations stained with the 
Gram method and on the diff erences in the results of biochemical identifi cation (API 
Candida system; API 20 STREP for Streptococci and API Staph, by bioMérieux, France 
for Staphylococci). Enterobacteriaceae spp. cultured on the McConkey agar were 
identifi ed using an API 20E set (bioMérieux, Lyon, France). Based on the coloration 
and morphology of yeast colonies on CHROMagarTM Candida, the isolates were 
identifi ed as Candida albicans. Th e biochemical diagnosis was performed according to 
the manufacturer’s instructions.
The bacteria species obtained in the tests were verified by means of mass 
spectrometry (MS) system MALDI with TOF (Bruker Daltonik, Germany). Prior to 
the identifi cation, a preliminary extraction was performed (using ethanol and formic 
acid). Two microliters of extract were placed on a metal plate and left  to dry at room 
temperature. Th e metal plate with applied samples was placed in the measurement 
chamber of the MALDI Biotyper apparatus and was subject to the action of a laser 
beam. Under the infl uence of desorption and bacterial protein ionization, the ionized 
peptides were accelerated in a strong electric fi eld and the ion TOF was measured. 
Based on the obtained distribution of peptides according to the molecular weight, 
charge and variable time-of-flight, the MALDI-TOF MS system automatically 
generated spectrometric peak spectra corresponding to ions with variable weight 
to charge ratios and analyzed the amount, intensity and correlation of peaks, as 
well as comparing the tested spectrum with reference spectra of microorganisms. 
Th e automatic spectrum measurement and its comparative analysis with standard 
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spectra was performed with an Ultrafl extreme mass spectrometer in combination 
with MALDI Biotyper 3.0 software (Bruker Daltonik, Germany) connected to 
the microorganism profile database. Based on this software, the spectral protein 
profi le was determined for the selected microorganisms. Th e likelihood of correct 
identifi cation in the MALDI Biotyper 3.0 soft ware was expressed in the form of 
a point indicator: 2,300 – 3,000 reliable identifi cation of a microorganism to the specifi c 
level; 2,000 – 2,299 reliable identifi cation of a microorganism to the generic level and 
probable result of identifi cation to the specifi c level; 1,700–1,999 reliable identifi cation 
result to the generic level; 0–1,699 unreliable identifi cation result.
Statistical analysis
Statistical analyzes were conducted using R soft ware, version 3.5.2 [22]. Normality 
was assessed with the Shapiro-Wilk test. Analyzes were conducted at a 0.05 level of 
signifi cance. Comparisons of qualitative variables in groups were conducted with the 
chi-squared test (with Yates’ correction for 2 × 2 tables) or with Fisher’s exact test 
(when low expected values occurred). Correlations between quantitative variables 
were assessed with Pearson’s (in cases of normal distribution of both variables) or 
Spearman’s (otherwise) correlation coeffi  cients. Strength of association was assessed 
with the following schema: |r| ≥0.9 — very strong, 0.7≤ |r| <0.9 — strong, 0.5≤ |r| <0.7 
— moderate, 0.3≤ |r| <0.5 — weak, |r| <0.3 — very weak [23]. Multivariate analysis 
of the simultaneous impact of many independent variables on one quantitative 
dependent variable was conducted by means of linear regression. 95% confi dence 
intervals were reported along with regression parameters. Comparisons of quantitative 
variables in more than two groups were conducted with ANOVA (in cases of normal 
distribution in each group) or with the Kruskal-Wallis test (otherwise). Fisher’s LSD 
test (in cases of normal distribution in each group) or Dunn’s test (otherwise) were 
used as post-hoc procedures.
Results
Demographic data and blood test results
Demographic data and results of blood morphology and biochemical tests in patients 
with CD and UC and in persons from the control group are listed in Table  1. No 
statistically signifi cant diff erences were found among the examined parameters 
(Table 1).
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Table 1. Th e results of blood tests in the studied groups of patients with ’Crohn’s disease, patients with 
ulcerative colitis and healthy persons in the control group.
Crohn’s disease Ulcerative colitis Control p*
Age (years)
Mean ± SD 40.18 ± 12.97 43.55 ± 13.65 55 ± 6.56 0.198
Median 40 41 54 P
Quartiles 28–48 33.5–49.5 51.5–58
Gender
Female 6 (33.33%) 9 (69.23%) 3 (100%) 0.067
Male 12 (66.67%) 4 (30.77%) 0 F
WBC [103/μL]
Mean ± SD 8.25 ± 3.67 9.32 ± 3.9 5.4 ± 1.78 0.27
Median 7.9 9.44 5.36 P
Quartiles 4.75–11.21 6.34–10.57 4.5–6.28
RBC [106/μL]
Mean ± SD 4.22 ± 0.62 4.22 ± 0.66 4.83 ± 0.35 0.291
Mediana 4.03 4.33 4.71 P
Quartiles 3.91–4.85 3.76–4.76 4.63–4.96
Hb [dL]
Mean ± SD 12.06 ± 1.7 11.93 ± 1.93 14.1 ± 0.56 0.156
Median 12.7 11.2 14 P
Quartiles 10.7–13.1 10.2–13.7 13.8–14.35
Ht [%]
Mean ± SD 36.92 ± 4.72 36.35 ± 4.57 42.33 ± 1.56 0.133
Median 37.3 35.7 42.5 P
Quartiles 33.2–39.4 32.15–40.5 41.6–43.15
MCV [fL]
Mean ± SD 88.34 ± 7.92 86.76 ± 7.11 87.97 ± 5.95 0.864
Mediana 89.1 86.3 89.5 P
Quartiles 84.4–93.2 83.2–88.1 85.45–91.25
Microcytes [%]
Mean ± SD 4.56 ± 5.54 3.91 ± 2.58 – 0.384
Median 1.7 3.25 – NP
Quartiles 1.03–5.62 1.88–5.95 –
Macrocytes [%]
Mean ± SD 4.5 ± 2.22 4.73 ± 2.32 – 0.895
Median 3.9 3.85 – NP
Quartiles 3.55–4.35 3.6–4.33 –
PLT [103/μL]
Mean ± SD 342.35 ± 101.09 362.45 ± 120.81 204 ± 78.89 0.063
Median 336 325 195 NP
Quartiles 245–401 312–384 162.5–241
Iron [μmol/l]
Mean ± SD 10.91 ± 7.92 6.7 ± 6.51 – 0.358
Median 8.02 6.7 – P
Quartiles 5.71–12.65 4.4–9.01 –
Albumin [g/l]
Mean ± SD 37.16 ± 6.18 39.67 ± 1.53 – 0.742
Median 37 40 – P
Quartiles 33.6–42.55 39–40.5 –
CRP [mg/l]
Mean ± SD 13.02 ± 18.33 9.04 ± 6.89 1 ± 0 0.057
Median 4.83 6.91 1 NP
Quartiles 2.84–9.2 4.77–13.72 1–1
Results are mean ± SD; no statistically signifi cant diff erences were observed when p >0.05.
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Microbiological identifi cation
Presented below are identifi cation results of strains of bacteria isolated from the 
mucous membrane of the oral cavity of patients with CD and patients with UC, as 
well as bacteria isolates from the mucosa of the cheeks and tongue collected from 
persons in control groups (without the above diseases). Th e identifi cation was carried 
out using biochemical methods and the MALDI-TOF MS technique. Th e majority of 
results obtained from biochemical identifi cation and with the use of the MS technique 
were consistent. Ultimately, the data were represented as a MALDI-TOF identifi cation 
result due to the higher probability of identifi cation being consistent with the real 
identifi cation (Table 2, Fig. 1).
Table 2. Identifi cation of isolated bacterial strains in patients with Crohn’s disease, ulcerative colitis and 
control group based on routine biochemical methods and MALDI-TOF MS technique.
Crohn’s disease
(n = 18)
Ulcerative colitis
(n = 13)
Control
(n = 3) p*
S. vestibularis 5 (27.78%) 2 (15.38%) 0 0.574 F
S. mitis 0 5 (38.46%) 1 (33.33%) 0.009 F
S. oralis 0 5 (38.46%) 2 (66.67%) 0.002 F
S. salivarius 2 (11.11%) 1 (7.69%) 2 (66.67%) 0.062 F
S. gordoni 2 (11.11%) 2 (15.38%) 0 1 F
S. sorbinus 0 1 (7.69%) 0 0.471 F
S. mutans 0 1 (7.69%) 0 0.471 F
S. downei 1 (5.56%) 0 0 1 F
S. parasanguinis 2 (11.11%) 4 (30.77%) 0 0.238 F
A. odontolyticus 2 (11.11%) 3 (23.08%) 0 0.771 F
A. oris 2 (11.11%) 1 (7.69%) 0 1 F
B. cereus 1 (5.56%) 0 0 1 F
L. fermentum 0 0 2 (66.67%) 0.005 F
N. fl avescens/sicca 0 1 (7.69%) 0 0.471 F
R. dentocariosa 4 (22.22%) 8 (61.54%) 0 0.046 F
R. mucilaginosa 6 (33.33%) 8 (61.54%) 2 (66.67%) 0.276 F
A. defectiva 1 (5.56%) 0 0 1 F
C. albicans 1 (5.56%) 0 0 1 F
*chi-square test, F-Fisher exact test (low expected values in the table).
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Fig. 1. Identifi cation of isolated bacterial strains in patients with Crohn’s disease (CD), ulcerative colitis 
(UC) and control group based on routine biochemical methods and MALDI-TOF MS technique.
In terms of the isolated species, the microbiota of patients with CD had the lowest 
diversity (Table 2, Fig. 1). Table 2 presents statistically signifi cant diff erences between 
the isolated species of the studied groups. Signifi cant diff erences between the groups 
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concerned the following species: S. mitis — this species was most common in the UC 
group and least common in the CD group; S. oralis was most common in the control 
group and the least common in CD. L. fermentum was only found in the control 
group, while R. dentocariosa was most common in the UC group and least common 
in the control group.
Total antioxidative potential (FRAP)
FRAP measured in the serum and in the saliva and the FRAP serum/saliva ratio 
in patients with CD, UC and in the control group diff ered statistically signifi cantly 
between all three parameters (p <0.05). Post-hoc analysis demonstrated that FRAP in 
saliva was signifi cantly higher in the UC group than in the CD group; FRAP in the 
saliva was signifi cantly higher in the control groups than UC, where it was signifi cantly 
higher than in the CD group. Th e ratio of FRAP in serum to FRAP in saliva was 
signifi cantly lower in UC and control groups than in the CD group. In patients with 
CD, FRAP in the serum was higher than FRAP in saliva (Table 3, Fig. 2).
Table 3. FRAP in saliva and serum and the ratio between FRAP in serum to FRAP in saliva in patients 
with Crohn’s disease, ulcerative colitis and in the control group. Statistically signifi cant diff erences 
between all three parameters (p <0.05).
Parameter Crohn’s disease-A.(n = 18)
Ulcerative colitis-B.
(n = 13)
Control-C.
(n = 3) p *
FRAP
[mM/g 
protein]
in saliva
Mean ± SD 0.04282 ± 0.00199 0.04556 ± 0.00245 0.04833 ± 0.00103 <0.001
Median 0.04325 0.0463 0.0486 P
Quartiles 0.0421–0.04385 0.0442–0.0473 0.0479–0.0489 C. B > A
FRAP
[mM/g 
protein]
in serum
Mean ± SD 0.06401 ± 0.00156 0.06607 ± 0.0024 0.06897 ± 0.00119 <0.001
Median 0.06435 0.0667 0.0686 P
Quartiles 0.06307–0.0648 0.064–0.0682 0.0683–0.06945 C > B > A
Serum/Saliva
FRAP
ratio
Mean ± SD 1.49764 ± 0.07977 1.45155 ± 0.03258 1.42702 ± 0.01466 0.007
Median 1.48224 1.4406 1.42886 NP
Quartiles 1.46979–1.49819 1.43154–1.47964 1.42019–1.43477 A > B. C
* P = normality of the distribution in groups, ANOVA + results of post-hoc analysis (LSD Fisher test); NP = no 
normality of distribution in groups, Kruskal-Wallis test and results of post-hoc analysis (Dunn’s test).
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Fig. 2. FRAP in saliva and serum and the ratio between FRAP in serum to FRAP in saliva in patients 
with Crohn’s disease (CD), ulcerative colitis (UC) and in the control group. Statistically signifi cant 
diff erences between all three parameters (p <0.05).
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Relationship between total antioxidative potential and infl ammation
Th e conducted study has demonstrated that CRP correlates signifi cantly and negatively 
with the FRAP levels in saliva and serum (p <0.05). Th us, the higher the CRP the 
lower the FRAP in both serum and saliva. In addition, CRP correlates signifi cantly 
and positively with the ratio of FRAP in serum to FRAP in saliva (p <0.05); thus, 
the higher the CRP the higher the ratio. Higher FRAP in serum than in saliva was 
observed (Table 4, Fig. 3).
Table 4. Relationships between serum CRP concentration and FRAP concentration in saliva and serum 
(p <0.05) and FRAP ratio in serum / saliva in the studied groups.
Parameter
Correlations with CRP
Correlation coeffi  cient p * Directionof correlation
Power
of dependence
FRAP in saliva –0.598 p = 0.001 NP Negative Medium
FRAP in serum –0.643 p <0.001 NP Negative Medium
Serum/saliva 0.473 p = 0.011 NP Positive Weak
* P = normal distribution of both correlated variables, Pearson’s correlation coeffi  cient; NP = No normality of 
distribution of at least one of the correlated variables, Spearman’s correlation coeffi  cient.
Fig. 3. Graphical presentations of relationships between CRP concentration in serum and FRAP 
concentrations in saliva and serum (p <0.05) and FRAP ratio in serum/saliva in the studied groups.
Discussion
Modern research on the microbiome has produced evidence that oral cavity diseases 
have a multifactorial basis [24, 25]. However, evidence for the occurrence of 
predominant microorganism species in CD is fragmentary and this frequently leads 
to inconsistent results [26, 27] and also relates the obtained results to healthy persons 
who remain outside of the hospital environment. Th e purpose of the conducted 
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study was to identify the bacteria colonizing mucous membranes of patients with 
CD in comparison with persons with UC on the gastroenterology ward of the 
University Hospital in Kraków. An assessment of the diversity of the oral cavity 
fl ora in selected patient groups was performed, and the occurrence of relationships 
between antioxidative defense in the oral cavity and on the periphery and generalized 
infl ammation was analyzed in selected patient groups.
Reduced antioxidative defense in the saliva of patients with CD was associated 
with the relatively lowest diversity of bacterial fl ora of the oral cavity and the strongest 
exhibition of infl ammation in the periphery. On the other hand, the slightly higher 
microbe species richness of the fl ora in patients with UC (Streptococcus salivarius 
group, Viridans streptococci, Lactobacillus, Actinomyces, classifi ed as pioneer species) 
was linked to a higher antioxidative potential (higher FRAP) compared with patients 
with CD and controls and to lower infl ammation intensity (lower CRP than that 
in patients with CD). Similar results were observed by Docktor et al. in a group 
of children with CD [28]. However, these researchers used healthy persons from 
outside of the hospital environment as the control relative to patients with CD. Th e 
richness and diversity of the bacterial fl ora of healthy persons outside of a hospital 
environment is not surprising [28, 29].
Reduced diversity of the bacterial flora of the oral cavity in patients with 
CD compared to UC may be associated with a higher iron level in the CD group 
compared to patients with UC. As demonstrated in the observations of Lee et al., 
iron metabolism is strictly linked to the composition of the intestinal flora of 
patients with infl ammatory bowel disease [30]. Th is has been proven by the fact 
that oral administration of iron preparations to UC patients reduces the diversity of 
bacterial phylotypes and their metabolites in stool in comparison to intravenous iron 
administration [30, 31].
The factors determining the variability of the bacterial flora composition in 
patients with CD or UC remain largely unknown; however, a higher share and 
contribution of OxS or infl ammation has been postulated as a modulator of the 
observed diff erences [32]. Microorganisms associated with OxS can be numerous, and 
only prospective research over time in selected patient groups will provide answers to 
the question as to whether and how the selected oral and intestinal microbiota species 
depend on oxidative defense, or whether ongoing systemic infl ammation is associated 
with OxS. As an example, Jurczak et al. showed that the oxidative-antioxidative 
balance was disturbed in children with caries due to shifts in oral microbiota 
composition and, depending on the isolated bacteria species, the antioxidative 
systems of the host supported or inhibited bacterial antioxidative systems [15]. Th us, 
the total antioxidative potential is the resultant of the host’s antioxidant action and 
antioxidants of the bacteria colonizing the oral cavity. Th is phenomenon may be 
explained by the fact that the bacteria that cause oral cavity diseases, e.g. caries, 
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present a strict relationship with environmental acidifi cation, as well with OxS, which 
are processes associated with elevated responses of bacterial enzymatic systems (the 
NADH-Nox intracellular oxidase system, coded NOx), or with the host’s enzymatic 
systems [33]. Th e growth of bacterial antioxidative systems, such as NADH oxidase, 
is accompanied by a decrease in the generation of ROS. Th erefore, it constitutes 
a specifi c survival form for certain bacteria species, for which the presence of genes for 
antioxidative enzymes in their genomes may be considered a signifi cant factor of their 
virulence  [34]. Th us far, reactions to OxS have only been studied in some bacteria 
species; apart from E. coli, Rothia mucilaginosa also possesses several genes associated 
with OxS (thioredoxin, mycothione reductase, reductase and oxydoreductase), which 
are considerably elevated under the impact of oxidative or nitrosative stress and 
which constitute the regulation factor for the redox state in the oral microbiome-host 
system [35, 36]. However, no detailed studies have been published on the eff ects of 
OxS among bacteria from the oral microbiome of patients with CD.
Both the oral-intestinal microbiota, as well as the cells of the immune system 
cells of the host may induce ROS production and OxS. Moreover, potential systemic 
causes or extrinsic factors, i.e. diet, impact the variability of both observed systems, 
i.e. oxidation-reduction in saliva or changes in the oral microbiome, which should 
not be omitted in an analysis of the impact of the aforementioned factors on health 
or disease [37].
In order to assess the relationship between the oral microbiota or the oral/
intestinal microbiota and OxS markers or infl ammation indicators, further prospective 
research is planned assessing the impact of daily rhythms or external environmental 
conditions (such as hospital or non-hospital environments, as well as diet) on changes 
over time in the oral-intestinal microbiota at the intra-individual level.
It is known that even slight changes over time in oral microbiota composition are 
signifi cantly related to the given host, in whom the elements of the immune system are 
widely diff erentiated and depend on health or disease condition. Th e vast majority of 
available studies on the microbiome in humans do not include individual populational 
diff erences determining intra-individual variability. It is also known that the oral-
intestinal microbiome demonstrates considerable variability throughout an individual’s 
life (for instance, at birth and in the subsequent hours the oral-intestinal microbiome 
of the child is subject to massive exposure to microorganisms originating from the 
external environment, e.g. breathing, breast-feeding and contact with parents and 
medical personnel). On the other hand, the permanent colonization of the oral cavity 
commences in the postpartum period. When a newborn child is only 24 hours old, 
pioneering microorganisms are being established which determine the composition of 
the oral-intestinal microbiome [38, 39]. Th us, all analyzes and conclusions concerning 
the oral-intestinal microbiota should be treated as a prospective study assessing the 
dynamics of these changes over time.
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Our results are in line with those of Gonze et al., which demonstrated that the 
microbiota may change between hosts even under the same environmental conditions, 
which means that intra-individual variability does not have to be associated with 
changes to the surrounding environmental conditions [40]. As presented in this 
study, the oral microbiota of a patient from a hospital environment may have a highly 
varied composition, expressed by the variability of colonization of specifi c ecological 
niches by selected microorganism species, and this may even be the case for patients 
on the same hospital ward, which is apparently associated with the colonization site 
of selected bacterial strains [41]. Th us, it appears valid to examine the microbiota of 
a given host with regards to their immune condition and the group of patients, to 
which the given person is qualifi ed, as well as the changes over time in those persons 
depending on their exposure to environmental factors. Research has shown that the 
microbiota characteristic of a given individual host is a combination of the host’s rich 
microbiota guaranteed by i.a. transmission of selected microorganism groups between 
individual hosts, and also the distribution of microorganisms in given ecological 
niches occupied by networks of microorganism species associated with the given host 
at a local level [42].
Moreover, research on the bacterial metagenome from the human microbiome 
has revealed that the unilateral approach to microbiome produces false results, as 
collection of single samples of material originating from persons from different 
environments and analysis of these samples in terms of correlations in the occurrence 
of selected microorganism species, e.g. Rothia, and co-occurrence of OxS in the given 
host has produced divergent results, i.e. 22.2% of such studies produced negative 
correlations, 0.1% observed positive correlations, and as many as 77.7% of cases 
were not linked to any signifi cant correlation [32]. In our study, the analysis of the 
relationship turned out to be diffi  cult due to the low number of examined persons, 
although the preliminary assessment favors a positive correlation associated with 
the occurrence of such species as R. mucilaginosa and R. dentocariosa with OxS 
and intensifi ed infl ammatory processes in the group of patients with non-specifi c 
infl ammatory intestinal diseases, i.e. CD and UC.
Intensifi cation of OxS associated with elevated ROS production does not have 
to be linked to overgrowth of bacterial fl ora, but it may be delayed over time [43]. 
Correlation profi les between selected microorganism species from the oral microbiota 
and OxS indicators and between inflammation markers appear to be unique 
characteristics of each species [44, 45]. A negative relationship was observed between 
e.g. Streptococcus and Rothia, and total antioxidative potential. Th e lower diversity of 
species which were predominant and characteristic for CD or UC correlated with OxS 
and infl ammation markers much more frequently than did common species (such as 
Viridans streptococci, Lactobacillus, Actinomyces). As an example, S. mitis and S. oralis 
were among the less common species in the CD group, although they demonstrated 
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considerable correlations with impaired antioxidative defense (lower FRAP) in the 
UC and control groups. However, those correlations were not statistically signifi cant 
in the examined UC and control groups. Although S. mitis and S. oralis are capable of 
inhibiting ROS in vitro, their activity may be inhibited by other microorganism species 
from the oral microbiota [46]. Naturally, it is highly likely that other bacteria species 
may impair the natural functions of S. mitis to inhibit ROS production, particularly 
in samples where S. mitis correlate with OxS indicators. Moreover, the oral microbiota 
is colonized by a range of bacteria species, which demonstrate variable capacity to 
produce or inhibit ROS, which constitutes their evolutionary adaptation increasing 
their survival chances in diffi  cult environmental conditions.
Oral microbiota profi les with indicators of lowered antioxidative defense, refl ecting 
intensifi cation of OxS, diff ered between persons from the hospital environment, which 
may be explained by various factors. Firstly, the variable metabolic activity of bacteria 
depending on the environment from which they were originally isolated is not taken 
into account when we consider species colonizing diff erent regions of the oral mucosa 
(surface of the tongue, cheeks, palate etc., associated with various functions), which 
may explain why the intra-individual correlation of determined bacterial models with 
the antioxidative defense markers is not uniform in separate individuals, even from 
the same patient group. Moreover, a study of the level of pure microorganism isolates 
may not fully mimic actual ROS production under the conditions of the oral cavity. 
Moreover, it has been demonstrated that selected bacteria species occurring in control 
subjects depend on the immune system of the host in diff erent manners. Th us, only 
selected microorganisms possess the capacity to produce ROS, which means that the 
results vary within separate individuals.
Although highly active metabolic bacterial cells and those which retain 
relationships with the immune system of the host can be determined quantitatively, 
it appears that it is diffi  cult to determine divergent species or those which live in 
metabolically inactive form or which attach to already formed ecosystems, changing 
their potential from being harmless to the host to being more pathogenic, stimulating 
ROS production under in vivo conditions. In our study, the appearance of specifi ed 
bacteria species correlated positively or negatively with elements of antioxidative 
defense, and, what is more, with an intensifi ed/lowered infl ammatory reaction in the 
CD, UC and control groups. Th is suggests that individual diff erences in compensating 
mechanisms exist for given patient groups as well as individual diff erences between 
individuals within groups. Th us, we cannot provide one universal template according 
to which selected bacteria species are bound with ROS production and have 
a synergistic or inhibitory eff ect with the human antioxidative system in the oral cavity.
Undoubtedly, modern advances of technology such as proteomics and 
metabolomics have a decisive importance in the determination of inter-individual 
differences at the level of human microbiome, and they may provide valuable 
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information on the determination of which microorganisms are associated with OxS 
locally or induction of infl ammation in the periphery, as well as of which bacteria 
determine the same metabolic function in the bodies of various hosts.
In the presented approach, the observations of the time-dependent dynamics of 
changes in oral microbiota composition may be of considerable importance.
In our future research we would like to verify the hypothesis concerning the 
impact of OxS and generalized infl ammation on the composition of the oral-intestinal 
microbiota and the impact of the external conditions on its composition in 
a  hospitalized group of patients with CD and other non-specifi c intestinal diseases, 
such as UC, which are our subject of interest.
In summary, assessment of the oral microbiota composition may provide 
information on the composition of the oral microbiome, which appears to be highly 
heterogeneous even in similar hospital conditions, i.e. the same hospital ward. 
Correlation analyses of individual samples from patients may provide ambiguous 
results. Th us, a study of changes in the dynamics of microbiota composition over time 
may enable estimation of the relationship of the selected bacteria species with the 
selected marker of OxS or the ongoing peripheral infl ammation within the selected 
patient groups.
Such considerations must take into account the existence of relationships between 
bacteria and other bacteria species (synergistic eff ect; one species supports another 
one-coexistence) and between bacteria and biochemical markers. In general, analysis 
of correlation has demonstrated that there are specifi c bacterial profi les (and not 
individual bacteria species) which are linked to OxS in humans. Generation of OxS 
and the functioning of antioxidative defense elements in the oral cavity in humans 
should be subject to more detailed research, since relationship analyses do not clearly 
demonstrate that certain microorganism species cause infl ammation while others do 
not.
Th e results of the present study underline the importance of oral cavity microbiota 
assessment in patients with CD, particularly in combination with other biochemical 
markers of the oral cavity or the system, such as CRP. Th e high costs of the test 
equipment required for assessment of the oral microbiome in hospitalized patients 
remain a limitation to the assessment, as in the case of DNA sequencing, which 
appears to be an adequate tool enabling analysis of a vast number of samples from 
a given hospital patient and their retrospective assessment over time for the purpose 
of enhanced diagnostics and monitoring of the state of patients and explaining the 
phenomena associated with the oral microbiome or hospital hazards associated with 
infections resistant to treatment.
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